Camlin Fine Sciences Ltd

Camlin Fine Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Camlin Fine Sciences Ltd

₹ 135 3.65%
15 Jan 4:01 p.m.
camlinfs.com BSE: 532834 NSE: CAMLINFINE
About

Camlin Fine Sciences is engaged in the Business of Speciality Chemicals.

Key Points

Business Verticals

Website BSE NSE
  • Market Cap ₹ 2,536 Cr.
  • Current Price ₹ 135
  • High / Low ₹ 142 / 78.1
  • Stock P/E
  • Book Value ₹ 36.7
  • Dividend Yield 0.00 %
  • ROCE 1.31 %
  • ROE -7.08 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Stock is trading at 3.67 times its book value
  • Company has low interest coverage ratio.
  • Company has a low return on equity of 1.96% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Part of BSE Allcap BSE Commodities BSE SmallCap

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
311 381 389 384 483 388 427 420 406 386 402 396 423
289 326 365 337 428 338 383 381 381 363 415 378 380
Operating Profit 23 55 24 47 55 50 44 39 25 23 -13 18 43
OPM % 7% 14% 6% 12% 11% 13% 10% 9% 6% 6% -3% 5% 10%
1 6 21 1 3 10 -8 6 2 2 -44 2 -138
Interest 9 7 10 19 18 12 10 10 20 14 16 23 26
Depreciation 13 13 16 14 14 16 18 19 19 21 20 20 21
Profit before tax 1 41 20 15 26 32 8 16 -12 -10 -94 -23 -142
Tax % 612% 33% 33% 75% 61% 28% 59% 25% 72% 47% -13% 48% -18%
-4 27 13 4 10 23 3 12 -21 -14 -82 -35 -116
EPS in Rs -0.39 2.01 0.86 0.33 0.74 1.36 0.52 0.83 -1.03 -0.63 -4.11 -1.81 -5.33
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
374 509 558 489 534 721 892 1,049 1,187 1,412 1,682 1,613 1,606
327 446 474 397 502 705 819 914 1,000 1,254 1,468 1,529 1,535
Operating Profit 47 63 84 92 32 16 73 135 187 158 213 84 71
OPM % 13% 12% 15% 19% 6% 2% 8% 13% 16% 11% 13% 5% 4%
10 9 9 -1 14 12 14 3 5 33 -4 -34 -179
Interest 20 25 24 24 31 32 41 48 42 41 66 70 80
Depreciation 14 12 16 17 22 27 29 33 44 56 63 79 81
Profit before tax 24 35 53 50 -6 -31 17 58 105 94 80 -99 -269
Tax % 36% 18% -4% 28% -26% -22% 82% 49% 38% 36% 50% 6%
15 29 55 36 -4 -24 3 30 65 60 40 -105 -247
EPS in Rs 1.43 2.71 5.11 3.30 -0.96 -2.18 0.04 2.23 3.56 3.45 2.96 -4.94 -11.88
Dividend Payout % 19% 12% 8% 12% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 12%
5 Years: 13%
3 Years: 11%
TTM: -2%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -367%
Stock Price CAGR
10 Years: 6%
5 Years: 12%
3 Years: -6%
1 Year: 5%
Return on Equity
10 Years: 4%
5 Years: 4%
3 Years: 2%
Last Year: -7%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 9 9 10 10 10 12 12 12 13 16 16 17 17
Reserves 56 84 125 167 202 359 359 391 631 732 804 848 673
126 150 160 180 331 373 461 539 550 646 801 683 767
178 126 131 123 126 273 255 290 282 396 425 424 429
Total Liabilities 369 369 426 479 669 1,016 1,087 1,232 1,475 1,790 2,045 1,972 1,885
83 83 106 140 201 278 272 306 584 601 858 816 721
CWIP 1 22 3 25 8 14 59 179 24 215 43 46 22
Investments 1 1 1 1 19 115 11 7 7 7 8 8 23
284 262 316 313 442 609 745 740 861 966 1,136 1,102 1,119
Total Assets 369 369 426 479 669 1,016 1,087 1,232 1,475 1,790 2,045 1,972 1,885

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
56 27 46 72 -9 -15 -9 86 117 145 51 139
-19 -32 -26 -66 -70 -149 -2 -90 -133 -249 -125 -66
-21 -6 -15 -7 91 182 26 3 39 136 60 -86
Net Cash Flow 16 -12 4 -1 13 18 15 -1 23 32 -14 -13

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 85 73 74 56 99 104 86 88 83 77 66 65
Inventory Days 330 145 184 311 277 207 219 204 200 178 255 216
Days Payable 349 132 144 171 110 154 127 119 99 112 129 130
Cash Conversion Cycle 66 85 114 196 266 157 178 173 184 143 192 151
Working Capital Days 72 71 91 109 178 144 143 120 123 103 125 121
ROCE % 24% 28% 28% 24% 5% 0% 7% 11% 13% 10% 10% 1%

Shareholding Pattern

Numbers in percentages

2 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
21.71% 17.65% 17.65% 17.64% 17.64% 17.64% 16.52% 48.03% 48.03% 48.04% 48.03% 48.03%
4.81% 10.50% 10.74% 11.32% 10.94% 10.18% 10.11% 1.61% 0.99% 1.69% 1.01% 0.81%
17.88% 14.47% 14.20% 13.53% 12.53% 12.32% 9.31% 3.89% 3.75% 4.55% 4.88% 4.23%
0.00% 0.00% 0.00% 0.00% 0.00% 0.03% 0.03% 0.00% 0.00% 0.00% 0.00% 0.00%
55.60% 57.37% 57.42% 57.52% 58.88% 59.82% 64.01% 46.46% 47.22% 45.73% 46.07% 46.93%
No. of Shareholders 56,39455,27757,83557,90454,19752,92152,27857,09862,09858,16562,68767,750

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls